| |
|
|
|
|
|||
| |
|
|
|
||||
 |
 |
|
 |
 SaluMedica's extensive research and development pipeline will produce products that will require regulatory approval or clearance by the United States Food and Drug Administration and comparable international regulatory agencies before becoming commercially available to patients. Currently, SaluMedica is focused on developing and manufacturing a peripheral nerve cuff implant and knee cartilage. |
|
 |
 |
 |
 |
 |
||
 |
 |
 |
|
|||
 |
|
|||||
 |
|
|||||
 |
|
|||||
 |
|
|||||
 |
|
|||||
 |
|
|||||
 |
 |
|
||||
 |
|
|||||
 |
|
|||||
 |
|
|||||
 |
|
|||||
|
Disclaimer:
The matters discussed herein may include forward-looking |
||